Infinity Pharmaceuticals | INFI - أصول متداولة





أصول متداولة تغيير تاريخ
AbbVie USD 29.06B 523M 2025-12
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 88.92M 8.72M 2025-09
CSL USD 11.85B 1000K 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Grifols EUR 6.28B 92.48M 2025-09
Incyte USD 5.02B 746.01M 2025-12
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
J&J USD 55.62B 1.01B 2025-12
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Plus Therapeutics USD 9.83M 1.75M 2023-12
Roche Holding CHF 38.73B 3.03B 2025-12
TG Therapeutics USD 630.76M 31M 2025-12